van Schaardenburg D
Rheumatology Clinic, Jan van Breemen Institute, Amsterdam, The Netherlands.
Drugs Aging. 1995 Jul;7(1):30-7. doi: 10.2165/00002512-199507010-00004.
Elderly-onset rheumatoid arthritis (EORA), defined as rheumatoid arthritis (RA) with onset at age 60 years or over, differs slightly from younger-onset RA by a more equal gender distribution, a higher frequency of acute systemic onset with involvement of the shoulder, a higher disease activity, and, in later stages, more radiographic damage and functional decline. Several subsets of EORA are recognised, such as rheumatoid factor-positive RA, polymyalgia rheumatica and 'remitting seronegative symmetrical synovitis with pitting oedema'. These conditions can be difficult to distinguish from crystal-induced arthritis, osteoarthritis and paraneoplastic arthritis. The efficacy and tolerability of second-line drugs is similar in both age groups, but in the elderly caution is needed with the use of nonsteroidal anti-inflammatory drugs and prednisone.
老年起病型类风湿关节炎(EORA)定义为60岁及以上发病的类风湿关节炎(RA),与年轻起病型RA略有不同,其性别分布更为均衡,急性全身起病伴肩部受累的频率更高,疾病活动度更高,且在疾病后期,影像学损伤和功能衰退更为严重。EORA有几个亚组,如类风湿因子阳性RA、风湿性多肌痛和“伴有凹陷性水肿的缓解性血清阴性对称性滑膜炎”。这些病症可能难以与晶体诱导的关节炎、骨关节炎和副肿瘤性关节炎相区分。二线药物在两个年龄组中的疗效和耐受性相似,但老年人使用非甾体抗炎药和泼尼松时需要谨慎。